We've now opened the call for abstracts, which can be sent by email (to this address), providing Title + Authors + Max 300 words, before March 1st 2016. We'll then work quickly to notify acceptance by around March 14th 2016.
The programme sounds interesting (I want to say "as usual" $-$ I know there's a bit of conflict there, given I'm in the Scientific Committee, but I do think so!), with the following invited speakers:
- Greg Campbell, FDA
- Mike Daniels, U Texas
- Kyle Wathen, Johnson and Johnson
- Tarek Haddad, Medtronic
- Martin Posch, U Vienna
- Alberto Sorrentino, Genova
- Robert Noble, GSK
Looking forward to this already!